These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1806 related articles for article (PubMed ID: 31530680)

  • 1. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an Alternative Modified Live Influenza B Virus Vaccine.
    Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
    Rudenko L; Kiseleva I; Krutikova E; Stepanova E; Rekstin A; Donina S; Pisareva M; Grigorieva E; Kryshen K; Muzhikyan A; Makarova M; Sparrow EG; Torelli G; Kieny MP
    PLoS One; 2018; 13(12):e0208028. PubMed ID: 30507951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.
    Nogales A; DeDiego ML; Topham DJ; Martínez-Sobrido L
    J Virol; 2016 Jul; 90(14):6291-6302. PubMed ID: 27122587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
    Ghorbani A; Ngunjiri JM; Xia M; Elaish M; Jang H; Mahesh KC; Abundo MC; Jiang X; Lee CW
    Vaccine; 2019 Feb; 37(10):1356-1364. PubMed ID: 30691981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus.
    Smith A; Rodriguez L; El Ghouayel M; Nogales A; Chamberlain JM; Sortino K; Reilly E; Feng C; Topham DJ; Martínez-Sobrido L; Dewhurst S
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs.
    Zheng M; Wang P; Song W; Lau SY; Liu S; Huang X; Mok BW; Liu YC; Chen Y; Yuen KY; Chen H
    J Virol; 2015 Oct; 89(20):10273-85. PubMed ID: 26223635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross- immunity of a H9N2 live attenuated influenza vaccine against H5N2 highly pathogenic avian influenza virus in chickens.
    Wang M; Wei Y; Pu J; Bing G; Sun Y; Sun H; Wei F; Liu J
    Vet Microbiol; 2018 Jul; 220():57-66. PubMed ID: 29885802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
    Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
    Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
    Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
    Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
    Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
    Korenkov DA; Laurie KL; Reading PC; Carolan LA; Chan KF; Isakova-Sivak II; Smolonogina TA; Subbarao K; Barr IG; Villanueva J; Shcherbik S; Bousse T; Rudenko LG
    Infect Genet Evol; 2018 Oct; 64():95-104. PubMed ID: 29929009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
    Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
    Front Immunol; 2019; 10():756. PubMed ID: 31105689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.
    Nicolodi C; Groiss F; Kiselev O; Wolschek M; Seipelt J; Muster T
    Vaccine; 2019 Jun; 37(28):3722-3729. PubMed ID: 31155415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines.
    Nogales A; Huang K; Chauché C; DeDiego ML; Murcia PR; Parrish CR; Martínez-Sobrido L
    Virology; 2017 Jan; 500():1-10. PubMed ID: 27750071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines.
    Shi S; Chen S; Han W; Wu B; Zhang X; Tang Y; Wang X; Zhu Y; Peng D; Liu X
    Vaccine; 2016 Jan; 34(3):350-7. PubMed ID: 26638027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.
    Li J; Arévalo MT; Chen Y; Chen S; Zeng M
    Int J Infect Dis; 2014 Oct; 27():37-43. PubMed ID: 25172265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 91.